Early increase in serum specific IgG2 upon allergen immunotherapy with a 300 IR sublingual house dust mite tablet
Allergy · 2023
DOI: 10.1111/all.15685 ↗Kurz gefasst
Leserbrief in der Zeitschrift Allergy, 2023. Verfasst von Nathalie Berjont und 6 weiteren Autor:innen. Beteiligte Einrichtung: Stallergenes Greer, Antony, France. Hauptthemen laut MEDLINE: Sublingual Immunotherapy, Rhinitis, Allergic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Stallergenes Greer, Antony, France.
- Department of Immunology, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
- Allergy, Asthma and Clinical Immunology, Alfred Health, Melbourne, Victoria, Australia.
- Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center IRCCS, Rozzano, Milan, Italy.
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
ORCID-Profile: Robyn E O'Hehir, Menno C van Zelm, Laurent Mascarell
Förderung
- National Health and Medical Research Council
Zitieren
APA
Berjont, N., Floch, V. V. B., O'Hehir, R. E., Canonica, W. G., van Zelm, M. C., Batard, T., & Mascarell, L. (2023). Early increase in serum specific IgG2 upon allergen immunotherapy with a 300 IR sublingual house dust mite tablet. Allergy. https://doi.org/10.1111/all.15685
Vancouver
Berjont N, Floch VVB, O'Hehir RE, Canonica WG, van Zelm MC, Batard T, et al. Early increase in serum specific IgG2 upon allergen immunotherapy with a 300 IR sublingual house dust mite tablet. Allergy. 2023. doi:10.1111/all.15685
BibTeX
@article{Berjont2023,
author = {Berjont, Nathalie and Floch, Véronique V Bordas-Le and O'Hehir, Robyn E and Canonica, Walter G and van Zelm, Menno C and Batard, Thierry and Mascarell, Laurent},
title = {Early increase in serum specific IgG2 upon allergen immunotherapy with a 300 IR sublingual house dust mite tablet},
journal = {Allergy},
year = {2023},
doi = {10.1111/all.15685}
}
EUVIMED